Top accelerator startups

14,448 startups · 29 programs

Rosebud Biosciences

Active · Growing micro-organs to find new drugs

7signal of 100 · rising 2
  • went through YCProgram · this site+4
  • team of 3Team size · YC's directory+3.1

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from W22 in AI

All of W22

About Rosebud Biosciences

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.

YC batch
W22 · Winter 2022
Status, per YC
Active
Category
AI
Team size
3
Location
San Francisco, CA, USA; San Carlos, CA, USA
Checked
7h ago

YC tags: AI-powered Drug Discovery, Pediatrics, Biotech

Rosebud Biosciences in W22: 398 companies, 45% AI

Rosebud Biosciences: questions

Which YC batch was Rosebud Biosciences in?

Rosebud Biosciences was in Y Combinator's Winter 2022 batch (W22).

Is Rosebud Biosciences still active?

Y Combinator lists Rosebud Biosciences as active.

Where is Rosebud Biosciences based?

Rosebud Biosciences lists San Francisco, CA, USA; San Carlos, CA, USA as its location on YC's directory.